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Published online: 16 December 2015 Ó Société Internationale de Chirurgie 2015 We read with interest the article entitled 'Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study' [1] . Congratulations to the authors for reporting the largest cohort of the patients having this rare disease. They have done a commendable job, considering that it was an analysis of a database and that data were collected over a long period of time. Having said this, we would like to make few comments and have some of our queries answered:
1. As we know, in case of pheochromocytoma, only the presence of metastases (distant or loco-regional lymph nodes) is widely accepted as a predictor of malignancy [2] . Does the database mention how the diagnosis of malignancy was arrived at, especially preoperatively (51.3 % patients were preoperatively diagnosed to have malignant disease [1] )? 2. In rest of the cases was malignancy diagnosed solely on the basis of histopathology or was metastasis found during the follow-up? 3. In how many cases were distant metastases found and what were the sites of metastases? 4. The range of tumor size mentioned in Table 1 is 2-300 mm [1] . How were tumors as small as 2 mm in size localized? Is it just an error while recording the data or a printing error? 5. In how many cases was the diagnosis of malignancy known before the patient underwent MIS and what were the outcomes (partial adrenalectomy/total adrenalectomy/conversion to open technique)? 6. 38.9 % patients in the minimally invasive surgery group (Table 2) [1] had partial adrenalectomies. Were these patients preoperatively planned to undergo palliative/debulking surgery or it was done because of technical reasons?
